Vertex Pharmaceuticals (VRTX) Inventory (2011 - 2026)

Vertex Pharmaceuticals' Inventory history runs 16 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• On a quarterly basis, Inventory rose 29.93% year-over-year to $1.8 billion in Q1 2026; TTM through Mar 2026 was $1.8 billion, a 29.93% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 39.94% from the prior year.
• Inventory advanced to $1.8 billion in Q1 2026 per VRTX's latest filing, from $1.7 billion in the prior quarter.
• Across five years, Inventory topped out at $1.8 billion in Q1 2026 and bottomed at $338.9 million in Q1 2022.
• The 5-year median for Inventory is $813.1 million (2024), against an average of $945.5 million.
• Across the five-year window, Inventory climbed 13.4% in 2022 and surged 77.41% in 2023, its largest moves.
• Year by year, Inventory stood at $460.6 million in 2022, then surged by 60.4% to $738.8 million in 2023, then soared by 63.16% to $1.2 billion in 2024, then jumped by 39.94% to $1.7 billion in 2025, then advanced by 4.74% to $1.8 billion in 2026.
• Per Business Quant, the three latest VRTX Inventory figures stand at $1.8 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.6 billion (Q3 2025).